The global e-prescribing market size is expected to touch USD 4,017.79 million by the end of 2026, attributable to the incorporation of e-prescribing software in the Electronic Health Record (EHR) solutions. E-prescribing or electronic prescribing is a new technologic infrastructure that helps the medical professionals to write and send prescriptions directly to the pharmacy. Fortune Business Insights, in its recent report, titled, “E-prescribing Market Size, Share & Industry Analysis, By Delivery Mode (Web-based, On-premise), By Prescription Type (Controlled substance, Non controlled Substances) By End User (Hospitals, Physician's offices, Pharmacies) and Regional Forecast, 2019-2026,” states that the value of the market was USD 863.64 million in 2018 and will exhibit a CAGR of 21.0% during 2019 to 2026.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/e-prescribing-market-102698
The current outbreak of the COVID-19 pandemic has stirred the global economy. Most of the international trade is at halt now, while some are struggling to generate meagre revenues. Governments of various nations have imposed safety regulations. We hope to fall out of this situation to a better one soon. Fortune Business Insights is offering a few individual reports on the impacts of coronavirus on various markets. These reports will benefit the investors to chalk out the revenue generation plans during this situation accordingly.
Cost-efficiency Features to Add Boost to Market
The e-prescribing software program allows doctors to transmit a prescription to the pharmacies and healthcare clinics without losing any medical history of the patient. This, coupled with the associated benefits, such as quality medical care and improved safety of the patients, are the key factors promoting the electronic prescribing market growth. Additionally, they are convenient for both the physician and the patient. They are more cost-efficient, as compared to the traditional prescription methods. It would, thereby augment the growth of the market during the forecast period.
On the flip side, implementing a new e-prescribing setup is expensive and requires high cost for maintenance, as well. This may hamper the market growth in the coming years. Nevertheless, the adoption of these therapeutic solutions in emerging economies is expected to create new opportunities for the market to flourish in the coming years. Nevertheless, the prevalence of various diseases requiring outpatient checkup services is likely to create lucrative growth opportunity in the near future.
Worldwide sales of the controlled substances closed in on a valuation of US$ 67,000 Mn in 2018, and are projected to record a Y-o-Y growth at 3.5% in 2019, according to a new Fact.MR study.
The study opines that depressants and stimulants have been top-selling class of drugs in the controlled substances market, however gains from marijuana are expected to record over 2X faster growth than all the other controlled substances in 2019 and beyond.The controlled substances market report highlights the following players:Teva Pharmaceuticals, Inc.Johnson & JohnsonDaiichi Sankyo CompanyTakeda Pharmaceutical Company LimitedOthersThe controlled substances market report examines the operating pattern of each player – new product launches, partnerships, and acquisitions – has been examined in detail.Approval of medical marijuana has been on a significant uptick in various states of the US, trailed by the legalization in Canada for both recreational and medicinal use recently.
This has tremendously contributed to the popularity of cannabis stocks, alongside efforts of leading controlled substance manufacturers toward eliminating legal barriers and attracting investor interest.
The study estimates marijuana sales in 2019 to record a Y-o-Y growth at 9.3% over 2018.Pain Management Remains Leading Application of Controlled SubstancesThe study opines that pain management will continue to account for over one-fourth share of the controlled substances market in 2018.
Several regulatory norms being implemented in the prescription of controlled substances for pain management, such as in Georgia, Michigan, and Florida, have further triggered the preference and adoption of controlled substances to manage and treat chronic as well as acute pain.
Attention deficit hyperactivity disorder (ADHD), and anxiety are other medical conditions wherein controlled substances are expected to witness promising future prospects, according to the study.Request For a Sample Report - https://www.factmr.com/connectus/sample?flag=S_id=2032The entrance of pharmaceutical giants in the cannabis sector of Canada alludes the next significant trend in the controlled substances industry, offering additional credibility to the sector.
Approval of medical marijuana has been on a significant uptick in various states of the US, trailed by the legalization in Canada for both recreational and medicinal use recently.
The study estimates marijuana sales in 2019 to record a Y-o-Y growth at 9.3% over 2018.Request for the Report Summary: https://www.factmr.com/report/2032/controlled-substances-market“The Schedule of Controlled Substances currently positions marijuana in Schedule 1 – the most restrictive one reserved for “high potential for abuse,” “lack of accepted safety” and “no accepted medical use” drugs.
Attention deficit hyperactivity disorder (ADHD), and anxiety are other medical conditions wherein controlled substances are expected to witness promising future prospects, according to the study.Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S_id=2032The entrance of pharmaceutical giants in the cannabis sector of Canada alludes the next significant trend in the controlled substances industry, offering additional credibility to the sector.
Big pharmaceutical companies that eye collaborations and partnerships with cannabis producers having competitive differentiation circling their R initiatives, commercialization efforts, and clinical trial programs, are likely to witness significant revenue generation in the near future.
Ensuring effective and safe management of controlled drugs continues to remain an imperative agenda among pharmacists, which in turn has led the focus on fundamental changes including reviewing of liquid CD management and CD documentation to realize substantial improvements.
The pharmacists are also adhering to the operational standards, completely aware about the way CDs are managed, along with identifying potential drawbacks and reporting concerns regarding non-conformance.
Looking into the global marketspace for controlled substances, Fact.MR has concluded some vital observations which highlights the burgeoning demand for such products.
According to this recently published study titled “Controlled Substances Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028”, it has been revealed that growing preference for medical marijuana over prescription drugs to control headaches, back problems, depression and pain, despite criminalization, indicates current public health structure that believes cannabis moderation becoming outdated.
This assessment carefully unravels essential data associated to prime market specifics including market outlook, demand side trends, pipeline assessment, Y-o-Y growth trend analysis, forecast factors as well as market dynamics that comprise of drivers, opportunity and restraints.Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S_id=2032Popularity of Medical Marijuana Uplifting Investor Interest towards Controlled Substances It has been noticed that approval of medical marijuana has turned out to be a significant boost in various states of the US.
Such events have greatly contributed to the popularity of cannabis shares, together with efforts of leading controlled substance companies toward abolishing legal barriers as well as attracting investor interest.
For example, in Georgia, Florida and Michigan, the triggered preference as well as adoption of controlled substances for treating chronic and acute pain have enhanced.
In addition, attention deficit hyperactivity disorder (ADHD), as well as anxiety are some other medical conditions which are managed using controlled substance.
The essential point of patient safety is to relieve the dangers, mistakes, and damage that can happen during the medical care time of a patient.
In the clinical network patient safety is the primary issue and the public authority should have to make fundamental strides.
Keen learning arrangements use visual components, like diagrams, pictures, graphs, and introductions, to assist understudies with getting a handle on the idea speedier.
This, thus, helps fabricate the premium degree of understudies in the subject understudies; consequently, they adapt successfully and are equipped for holding more data.
It likewise functions as a directing power in honing the innovative creative mind force of understudies.PTFE Vascular Grafts Market needs to incorporate the segment, cutthroat, and business data, alongside the client’s information, to discover the complexities.
Associations are attempting to zero in on breaking down the deals and different business sectors to distinguish the holes.
Clients these days have become brand cognizant.
They request better quality, lower costs and quicker conveyance of items and administrations.
